News Medical

Study shows angiotensin-converting enzyme 2 decoy protein as a promising anti-SARS-CoV-2 agent

In a recent study posted to the bioRxiv* preprint server, researchers presented a microbody recombinant decoy protein with high affinity to angiotensin-converting enzyme 2 (ACE2) as an option for ...
ascopubs.org

Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer.

The prognostic impact of KRAS mutation in colorectal cancer patients: A meta-analysis of phase III clinical trials. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract ...
ascopubs.org

Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on immunotherapy efficacy in advanced hepatocellular carcinoma.

First-line durvalumab with arterial chemotherapy in major portal invaded hepatocellular carcinoma: The phase 2 DurHope study with biomolecular analyses. Comparative diagnostic accuracy and tumor ...
News Medical

Study suggests Alzheimer’s disease diagnosis is associated with higher levels of soluble ACE2 in the human brain

In a recent study posted to the bioRxiv* preprint server, researchers investigated ACE2 (angiotensin-converting enzyme 2) levels among individuals with AD (Alzheimer’s disease). Study: Higher ...
Science Daily

COVID-19 antibody discovery could explain long COVID

Researchers discover that the COVID-19 virus can trigger the production of 'abzymes' -- antibodies that act like enzymes -- which may explain why long COVID symptoms persist even after the infection ...